Tahari, Norsheila .
HRN: 11-77-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2023
CEFUROXIME 500MG (TAB)
03/15/2023
03/22/2023
ORAL
500 Mg
Twice A Day For 7 Days
Infection
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes